Pre-Clinical Assessment of 177Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease

Author: Ray Geoffrey L.   Baidoo Kwamena E.   Keller Lanea M. M.   Albert Paul S.   Brechbiel Martin W.   Milenic Diane E.  

Publisher: MDPI

E-ISSN: 1424-8247|5|1|1-15

ISSN: 1424-8247

Source: Pharmaceuticals, Vol.5, Iss.1, 2011-12, pp. : 1-15

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content